It is not approved by the FDA for fat loss or any other use, and any clinical application falls under the supervision of a licensed medical provider
indicated that the peptide reduced over 50% of body weight gain in these laboratory models compared to controls, with heightened lipolytic activity observed within the adipose tissues of exposed rats, alongside an absence of notable disruptions in insulin sensitivity in these experimental settings
In aged mice treated for 8 weeks at 10 mg/kg daily, sedentary mice showed approximately 40% greater grip strength than controls, and when combined with exercise, grip strength improved by approximately 60%
Also, there were significant improvements in cardiovascular and metabolic risk factors among patients treated with Qnexa [246]
Work with your clinician to review sources, confirm results, and assess contributing factors